We’re improving your experience!

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05641428
Title Comparison of Point-of-care Produced CAR T-cell With Commercial CAR T-cells in Patients With R/R LBCL (HOVON161)
Acronym HOVON161
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Medical Center Groningen
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD

Facility Status City State Zip Country Details
NL-Amsterdam-AMC RECRUITING Amsterdam Netherlands Details
NL-Groningen-UMCG RECRUITING Groningen Netherlands Details
NL-Leiden-LUMC RECRUITING Leiden Netherlands Details
NL-Maastricht-MUMC RECRUITING Maastricht Netherlands Details
NL-Nijmegen-RADBOUDUMC RECRUITING Nijmegen Netherlands Details
NL-Rotterdam-ERASMUSMC RECRUITING Rotterdam Netherlands Details
NL-Utrecht-UMCUTRECHT RECRUITING Utrecht Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field